NCT03142542

The Efficacy and Safety of Udenafil in Patients With Erectile Dysfunction After Bilateral Nerve-sparing Radical Prostatectomy

A Randomized, Double-blind, Placebo-controlled, Investigator Initiated Clinical Trial to Evaluate the Efficacy and Safety of Udenafil Dosed Once a Day in Patients With Erectile Dysfunction After Bilateral Nerve-sparing Radical Prostatectomy

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 99 (estimated)
• Sponsor: Samsung Medical Center · Academic / Other
• Sex: Male
• Age: 20 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

This study evaluates the efficacy and safety of Udenafil dosed once a day in patients with erectile dysfunction after bilateral nerve-sparing radical prostatectomy.

Conditions

• Prostate Cancer With Radical Prostatectomy

Interventions

Type	Name	Description
DRUG	ZYDENA TAB.75mg(Udenafil 75mg)	ZYDENA TAB.75mg(Udenafil 75mg): by mouth, Once daily, for 32 weeks
DRUG	Placebo Oral Tablet	Placebo Oral Tablet: by mouth, Once daily, for 32 weeks

Timeline

• Start date: 2017-05-01
• Primary completion: 2019-05-01
• Completion: 2019-12-01
• First posted: 2017-05-05
• Last updated: 2017-05-05